@prefix dc: .
@prefix this: .
@prefix sub: .
@prefix beldoc: .
@prefix rdfs: .
@prefix rdf: .
@prefix xsd: .
@prefix dce: .
@prefix pav: .
@prefix np: .
@prefix belv: .
@prefix prov: .
@prefix Protein: .
@prefix hgnc: .
@prefix geneProductOf: .
@prefix hasPart: .
@prefix chebi: .
@prefix go: .
@prefix pfh: .
@prefix hasAgent: .
@prefix atcc: .
@prefix occursIn: .
@prefix hasAnnotation: .
@prefix mesh: .
@prefix species: .
@prefix pubmed: .
@prefix orcid: .
sub:Head {
this: np:hasAssertion sub:assertion;
np:hasProvenance sub:provenance;
np:hasPublicationInfo sub:pubinfo;
a np:Nanopublication .
}
sub:assertion {
sub:_1 hasPart: chebi:59826, sub:_2 .
sub:_2 geneProductOf: hgnc:9445;
a Protein: .
sub:_3 hasAgent: sub:_4;
a go:0042789 .
sub:_4 geneProductOf: pfh:STAT5%20Family;
a Protein: .
sub:_5 occursIn: mesh:D001943, mesh:D042361, atcc:HTB-133.aspx, species:9606;
hasAnnotation: sub:_6;
rdf:object sub:_3;
rdf:predicate belv:increases;
rdf:subject sub:_1;
a rdf:Statement .
sub:_6 dc:subject "TextLocation";
rdf:value "Results" .
sub:assertion rdfs:label "composite(p(HGNC:PRL),a(CHEBIID:59826)) -> tscript(p(PFH:\"STAT5 Family\"))" .
}
sub:provenance {
beldoc: dce:description "Approximately 2000 hand curated statements drawn from 57 PubMeds.";
dce:rights "Copyright (c) 2011-2012, Selventa. All Rights Reserved.";
dce:title "BEL Framework Small Corpus Document";
dc:license "Creative Commons Attribution-Non-Commercial-ShareAlike 3.0 Unported License";
pav:authoredBy sub:_8;
pav:version "1.6" .
sub:_7 prov:value """The β-casein promoter, known to be induced by Stat5 when activated by prolactin via
prolactin receptors and JAK2, was next used to test the function of the phosphorylated
Stat5. T47D-YB cells were pretreated with either R5020 or ethanol vehicle
for 48 h. Cells were then washed, transfected with a β-casein promoter-luciferase
reporter, treated with either R5020 or prolactin, and harvested for luciferase
assay 24 h after hormone treatment. We found that in T47D-YB breast cancer
cells, prolactin alone has minimal to no significant effect on the β-casein luciferase
promoter. However, after R5020 pretreatment, a 6–7-fold induction of the
β-casein luciferase promoter was observed (Fig.7B). Thus R5020 sensitized these
breast cancer cells to the transcriptional effects of prolactin mediated through
Stat5.""";
prov:wasQuotedFrom pubmed:9813040 .
sub:_8 rdfs:comment "support@belframework.org";
rdfs:label "Selventa" .
sub:assertion prov:hadPrimarySource pubmed:9813040;
prov:wasDerivedFrom beldoc:, sub:_7 .
}
sub:pubinfo {
this: dc:created "2014-07-03T14:29:30.808+02:00"^^xsd:dateTime;
pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 .
}